Posts by: Teresa Carvalho

Teresa Carvalho

March 8, 2021March 9, 2021

Safety Board Says Phase 2 Temelimab Trial Should Move Forward

News

A Phase 2a clinical trial evaluating GeNeuro‘s investigational antibody temelimab as a treatment for relapsing multiple sclerosis (MS) should continue as planned, without modifications. That’s the recommendation of a Drug ... Read more

March 4, 2021March 4, 2021

BMS Grants to National MS Society, Others Aim for Diversity in Care and Trials

News

The National Multiple Sclerosis Society was among 56 nonprofit organizations chosen by Bristol Myers Squibb to share an $11 million award supporting projects that promote health equity and access to better care across ... Read more

February 9, 2021February 9, 2021

Tool to Potentially Diagnose MS via Eye Movements Gets $2.5M Funding Boost

News

C. Light Technologies announced it raised $2.5 million in seed funding to further develop a noninvasive eye tracking device that might diagnose multiple sclerosis (MS) and other neurological diseases through measures made ... Read more

February 5, 2021February 5, 2021

MS Society of Canada Grant Supports Trial of Metformin in Young Patients

News

Multiple Sclerosis Society of Canada have given CA$400,000 (about $312,500) to support a pilot clinical trial investigating the potential of metformin, a common diabetes therapy, to treat children and young ... Read more

February 4, 2021February 4, 2021

Online Art Auction Supports National MS Society

News

An online auction event supporting the National Multiple Sclerosis Society  is is running through Feb. 13 on Facebook. Organized by The Dyeing Arts group, the fundraising auction features tie dye and ... Read more

February 3, 2021February 3, 2021

New Center to Advance Research on MS, Neurovascular Disorders

News

A $2.5 million donation from the Simon Family Trust is supporting the creation of a new center of expertise to help in the development of new therapies for multiple sclerosis ... Read more

February 2, 2021February 3, 2021

European Project Uses Artificial Intelligence to Help Improve Patient Care

News

The recently launched BRAINTEASER project focuses on the use of artificial intelligence (AI) technology to improve the care of patients with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). An ... Read more

January 27, 2021January 27, 2021

Age Found to Be Main Driver of MS Disability, Patient Therapy Response

News

Age is a main driver of disability in multiple sclerosis (MS) and has a key influence on patients’ therapeutic responses to Tecfidera (dimethyl fumarate) and Tysabri (natalizumab), a study showed. ... Read more

January 21, 2021January 21, 2021

New Study Will Assess Tysabri Effects on MS Cognitive Fatigue

News

Researchers from the Kessler Foundation will launch a new study investigating the effects of Tysabri (natalizumab) on cognitive fatigue — the type of fatigue that happens after strong mental concentration, ... Read more

November 13, 2020November 13, 2020

Start2Cure Foundation Awards Grant to MS Gene Therapy Project

News

Start2Cure Foundation is funding a research project that will investigate the potential of a gene therapy approach to treat multiple sclerosis (MS). MS is an autoimmune disease characterized by the damage ... Read more

November 11, 2020November 12, 2020

Air Pollution, Once Inhaled, Seen to Trigger Inflammation in RRMS Patients

News

Exposure to air pollution, particularly to particulate matter 10 (PM10), small airborne and inhalable particles, may trigger inflammatory reactions in people with multiple sclerosis (MS), an Italian study reported. The study “Air pollution ... Read more

November 9, 2020November 9, 2020

Tysabri Superior to Gilenya at Easing Activity in RRMS, Study Reports

News

Treatment with Tysabri (natalizumab) was more effective than Gilenya (fingolimod) in helping people with relapsing–remitting multiple sclerosis (RRMS) achieve no evidence of disease activity, a head-to-head study suggested. The study, “BEST-MS: ... Read more

November 2, 2020November 2, 2020

People With MS Invited to Submit Their Art for 2021 MSAA Art Showcase

News

People with multiple sclerosis (MS) are invited to submit their artwork to the Multiple Sclerosis Association of America‘s (MSAA) annual Art Showcase. The online event aims to share the work ... Read more

October 29, 2020October 29, 2020

Newly Discovered Type of Immune Cells May Be Key in Treating MS

News

A recently identified group of immune cells saved damaged nerve cells from death and promoted nervous system repair, a new study suggests. This finding may represent new promise for treating ... Read more

October 14, 2020October 14, 2020

Caregivers of Youth With MS, Other Ills Invited to Survey on Mental Health

News

Access to mental health services for children with a rare disease or other medical or mental health disorder is the focus of an online survey by therapists at Children’s Friend, ... Read more

October 13, 2020October 13, 2020

Risk Factors for Unemployment in People With MS Identified in Study

News

Factors related to disease and personality, as well as specific health-related behaviors, are among the main determinants that can put people with multiple sclerosis (MS) at risk of unemployment, a ... Read more

October 12, 2020October 12, 2020

Compounds Targeting Inflammatory C-reactive Protein Under Study in Australia

News

A search is on for an anti-inflammatory treatment targeting the C-reactive protein — CRP, a biomarker of inflammation produced by the liver — of possible use in a wide variety of conditions, including immune-mediated ... Read more

October 6, 2020October 6, 2020

Hypertension Quite Common Among MS Patients in US, Study Finds

News

Hypertension is considerably more common among people with multiple sclerosis (MS) in the United States than among those without the disease, a large data study reported. High blood pressure was ... Read more

September 28, 2020September 28, 2020

High Co-occurrence of Psychiatric, Cardiovascular Diseases in MS, Study Reports

News

People with multiple sclerosis (MS) show a high occurrence of comorbidities — two diseases occurring in one person at the same time — with psychiatric and cardiovascular diseases being the ... Read more

September 23, 2020September 23, 2020

Siemens Healthineers, Novartis Partner to Develop NfL Diagnostic Test

News

The development of a diagnostic test using neurofilament light chain (NfL) — a biomarker for nerve cell damage — for people with multiple sclerosis (MS) will be part of a ... Read more